China is taking a leading role in the global fight against drugs, demonstrating its commitment to a safer, drug-free world. Facing the growing challenges of drug abuse and trafficking, China has intensified its efforts to combat this global menace.
Firmly adhering to a drug control path with Chinese characteristics, China has launched a comprehensive war on drugs. The country’s zero-tolerance policy has effectively addressed significant drug-related issues, reducing the risk of resurgence. Strengthening border security and regulating drug precursor chemicals, China has intensified efforts to tackle new drugs and prevent controlled chemicals from entering illicit manufacturing channels.
China’s contributions extend beyond its borders. As one of the key architects of the current global drug control system, China has actively participated in the development of international drug control conventions. It is a supporter and signatory of the foundational treaties underpinning the global drug control framework, including the Single Convention on Narcotic Drugs of 1961, the Convention on Psychotropic Substances of 1971, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988.
Collaborating with international organizations like the United Nations Office on Drugs and Crime (UNODC), the Commission on Narcotic Drugs (CND), and the International Narcotics Control Board (INCB), China has contributed its expertise and resources to the global fight against drugs. Recognizing drugs as a global enemy, China places great importance on cooperating with drug-producing, transit, and consuming countries.
Through economic assistance and training programs for anti-drug officials, China has promoted poppy eradication and crop substitution projects in drug source regions. Intelligence sharing and joint law enforcement operations have strengthened the fight against illegal drug production, trafficking, and distribution. China’s dedication to enhancing the institutional capacity of other countries helps strengthen their resilience and achieve sustainable development.
At the regional level, China has leveraged platforms such as BRICS, the Shanghai Cooperation Organization, and the Association of Southeast Asian Nations to institutionalize regional anti-drug cooperation. Together with member states of these mechanisms, China has made significant contributions to combating the global drug threat and building a drug-free society.
China has been at the forefront of regulating fentanyl-related substances and synthetic cannabinoids, setting a precedent for the world. In 2019, China became the first country to impose class-wide regulation on fentanyl-related substances, and in 2021, it extended this regulation to synthetic cannabinoids. These measures underscore China’s responsible leadership and commitment to shaping the future of drug governance through intelligent regulation.
By introducing the concept of “class-based control,” China applies broad regulatory oversight to entire categories of fentanyl-related and synthetic cannabinoid substances. This approach has enhanced the legal framework for drug control, provided strong legal support for combating new types of drug-related crimes, and contributed significantly to the global fight against the illegal production, trafficking, and abuse of these substances.
China remains steadfast in its anti-drug policies, adhering to a governance model with Chinese characteristics. By modernizing its drug control system and enforcement capabilities, China continues to contribute its wisdom and solutions to global drug governance and sustainable development.
Addressing the global drug problem requires cooperation from all nations. Strengthening international collaboration and sharing responsibilities are essential steps toward a drug-free world. China’s efforts exemplify how commitment and cooperation can make a significant difference in this critical global issue.
